Skip to main content

Table 3 Main toxicity in 70 patients

From: FOLFIRI as a second-line therapy in patients with docetaxel-pretreated gastric cancer: a historical cohort

Toxicity Grade 3 (%) Grade 4 (%)
Neutropeniaa 21.5 7
Anemia 7 -
Thrombocytopenia 3 -
Diarrhea 13 1.4
Nausea/vomiting 6 -
Mucositis 6 -
Fatigue 6 -
Hepatotoxicity 3 -
  1. aFour episodes of febrile neutropenia in 3 patients (4%).